SNHG18 and central nervous system cancer: In addition, SNHG18 promoted radiological resistance of glioma by inhibiting semaphore 5A and promoted glioma cell movement by disrupting α-enolase nucleoplasmic transport (Zheng et al., 2016, 2019).